Matthew J. Zirwas MD
Director, Contact Dermatitis Center, Ohio State University, Gahanna, OhioDr. Zirwas is the Director of the Contact Dermatitis Center at The Ohio State University, where he is also the residency program director for dermatology.
Disclosures
Dr. Zirwas is a speaker and consultant for Pfizer, Abbvie, Sanofi, Regeneron, Leo, Galderma and Incyte.Recent Contributions to PracticeUpdate:
- Assessing the Impact of Prior Authorizations on Dermatology Residents
- New Understanding of the Environmental Causes of Atopic Dermatitis
- Real-World Evidence on the Use of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
- Analysis of Contact Allergens in Single-Use Polyvinyl Chloride Medical Examination Gloves in the US
- Effect of Upadacitinib on Atopic Hand Eczema in Patients With Moderate to Severe Atopic Dermatitis
- Allergens in Common Brands of Clobetasol
- North American Contact Dermatitis Group Patch Test Results From 2019 to 2020
- Early Itch Response With Abrocitinib Is Associated With Later Efficacy Outcomes in Patients With Moderate to Severe Atopic Dermatitis
- Efficacy of a Standardized Skin Care Regimen to Prevent Atopic Dermatitis in Infants at Risk for Atopy
- Food-Induced Skin and Mucosal Pruritus: Clinical Characteristics, Pathophysiology, and Recommendations